Veru Inc. (VERU)
NASDAQ·Healthcare·Biotechnology
$2.34
+0.00%
Mkt Cap $39.48M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 11, 2026 | $2.10M | — | — | -$0.47 | -$0.26 | +44.68% | — | — |
| Q4 2025 Dec 17, 2025 | — | $247.06K | — | -$0.36 | -$0.60 | -64.38% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.55 | -$0.50 | +9.09% | — | — |
| Q2 2025 May 8, 2025 | $725.00K | — | — | -$0.06 | -$0.05 | +16.67% | — | — |
| Q1 2025 Feb 13, 2025 | $3.02M | — | — | -$0.08 | -$0.07 | +12.50% | — | — |
| Q4 2024 Dec 16, 2024 | $3.56M | $6.66M | +86.98% | -$0.07 | -$0.06 | +14.29% | — | — |
| Q3 2024 Aug 8, 2024 | $3.56M | $3.95M | +11.06% | -$0.06 | -$0.07 | -16.67% | — | — |
| Q2 2024 May 8, 2024 | $3.00M | $4.14M | +37.84% | -$0.05 | -$0.07 | -40.00% | — | — |
| Q2 2024 Apr 1, 2024 | $5.20M | $2.14M | -58.83% | -$0.10 | -$0.09 | +10.00% | — | — |
| Q4 2023 Dec 8, 2023 | $3.95M | $3.86M | -2.23% | -$0.20 | -$0.16 | +20.00% | — | — |
| Q3 2023 Aug 10, 2023 | $3.95M | $3.34M | -15.41% | -$0.20 | -$0.13 | +35.00% | — | — |
| Q2 2023 May 11, 2023 | $4.32M | $6.59M | +52.45% | -$0.33 | -$0.44 | -33.33% | — | — |
| Q1 2023 Feb 9, 2023 | $5.07M | $2.51M | -50.50% | -$0.38 | -$0.46 | -21.05% | — | — |
| Q4 2022 Dec 5, 2022 | $11.55M | $2.59M | -77.59% | -$0.29 | -$0.51 | -75.86% | — | — |
| Q3 2022 Aug 11, 2022 | $16.67M | $9.60M | -42.39% | -$0.18 | -$0.28 | -55.56% | — | — |
| Q2 2022 May 12, 2022 | $12.21M | $13.03M | +6.72% | -$0.16 | -$0.18 | -12.50% | — | — |
| Q1 2022 Feb 9, 2022 | $13.84M | $14.14M | +2.12% | -$0.11 | -$0.08 | +27.27% | — | — |
| Q4 2021 Dec 2, 2021 | $13.00M | $15.65M | +20.36% | -$0.08 | -$0.05 | +37.50% | — | — |
| Q3 2021 Aug 12, 2021 | $14.10M | $17.66M | +25.22% | -$0.06 | -$0.03 | +50.00% | — | — |
| Q2 2021 May 12, 2021 | $13.34M | $13.34M | +0.00% | -$0.04 | -$0.04 | -5.26% | — | — |